European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Veterinary medicines European public assessment report (EPAR): Lotilaner / Milbemycin Elanco, lotilaner,milbemycin oxime, Status: Authorised

Submitted by Anonymous (not verified) on 2 March 2026 - 16:22

Veterinary medicines European public assessment report (EPAR): Lotilaner / Milbemycin Elanco, lotilaner,milbemycin oxime, Status: Authorised

Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Date of authorisation: 07/06/2010, Revision: 32, Status: Authorised

Submitted by Anonymous (not verified) on 2 March 2026 - 16:15

Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Date of authorisation: 07/06/2010, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 34, Status: Authorised

Submitted by Anonymous (not verified) on 2 March 2026 - 16:08

Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 2 March 2026 - 16:02

Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 11, Status: Authorised

Submitted by Anonymous (not verified) on 2 March 2026 - 15:58

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 2 March 2026 - 15:55

Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 28, Status: Authorised

3Rs Working Party (3RsWP) stakeholder meeting - Public session on the 2026-2028 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 31 March 2026, 09:30 (CEST) to 31 March 2026, 10:30 (CEST)

Submitted by Anonymous (not verified) on 2 March 2026 - 15:49

3Rs Working Party (3RsWP) stakeholder meeting - Public session on the 2026-2028 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 31 March 2026, 09:30 (CEST) to 31 March 2026, 10:30 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More